Usage summary
Strongest role: Inclusion Required
Inclusion-required count: 5
Treatment-assignment count: 0
Stratification count: 1
breast cancer · Combination Therapy
PD-L1 expression is flagged as cdx established context because public trials show inclusion required evidence in 14 contexts. FDA CDx context exists.
Strongest role: Inclusion Required
Inclusion-required count: 5
Treatment-assignment count: 0
Stratification count: 1
Threshold count: 0
Common snippets: None extracted
Threshold label: Low
CDx label: Fda Cdx Context Exists
CDx maturity score: 5/5
Confidence: High
Signal count: 1
Recent signals: 1
Density label: Low
https://clinicaltrials.gov/study/NCT07153965 | https://clinicaltrials.gov/study/NCT05253053 | https://clinicaltrials.gov/study/NCT07544056 | https://clinicaltrials.gov/study/NCT03202316 | https://clinicaltrials.gov/study/NCT04130152 | https://clinicaltrials.gov/study/NCT06394661 | https://clinicaltrials.gov/study/NCT03395899 | https://clinicaltrials.gov/study/NCT04872985 | https://clinicaltrials.gov/study/NCT07187674 | https://clinicaltrials.gov/study/NCT05068141 | https://clinicaltrials.gov/study/NCT06067061 | https://clinicaltrials.gov/study/NCT07045311 | https://clinicaltrials.gov/study/NCT06889688 | https://clinicaltrials.gov/study/NCT04913571